IN2012DN00904A - - Google Patents
Info
- Publication number
- IN2012DN00904A IN2012DN00904A IN904DEN2012A IN2012DN00904A IN 2012DN00904 A IN2012DN00904 A IN 2012DN00904A IN 904DEN2012 A IN904DEN2012 A IN 904DEN2012A IN 2012DN00904 A IN2012DN00904 A IN 2012DN00904A
- Authority
- IN
- India
- Prior art keywords
- formula
- group
- bonded
- serotonin
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Abstract
Provided is a new serotonin-reuptake inhibitor that exhibits affinity for serotonin-1A receptors. Said serotonin-reuptake inhibitor is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. In the formula, R1 represents a hydrogen atom, a 2-hydroxyethyl group, or a 2-methoxyethyl group. R2 represents one of the following bonded to a methylene group which is bonded to a piperidine ring: a chlorine atom bonded in a p-position; a bromine atom bonded in a p-position; a methyl group bonded in a p-position; a chlorine atom bonded in an m-position; or a bromine atom bonded in an m-position. Either Y1 represents a hydrogen atom and Y2 represents a hydrogen atom or a hydroxyl group, or Y1 and Y2 together represent an oxo group. Z represents a group represented by one of the following formulas: formula (3-1-1), formula (3-1-2), formula (3-2-1), formula (3-2-2), formula (3-3-1), formula (3-3-2), formula (3-4-1), or formula (3-4-2). However, if R1 represents a 2-hydroxyethyl group or a 2-methoxyethyl group and Y1 and Y2 both simultaneously represent hydrogen atoms, then Z represents a group represented by one of the following formulas: formula (3-1-2), formula (3-2-1), formula (3-2-2), formula (3-3-1), formula (3-3-2), formula (3-4-1), or formula (3-4-2).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009181550 | 2009-08-04 | ||
PCT/JP2010/063148 WO2011016468A1 (en) | 2009-08-04 | 2010-08-04 | Benzyl piperidine compound |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00904A true IN2012DN00904A (en) | 2015-04-03 |
Family
ID=43544363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN904DEN2012 IN2012DN00904A (en) | 2009-08-04 | 2010-08-04 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8778970B2 (en) |
EP (1) | EP2463286A4 (en) |
JP (1) | JPWO2011016468A1 (en) |
KR (1) | KR20120051716A (en) |
CN (1) | CN102482263A (en) |
AU (1) | AU2010279963A1 (en) |
CA (1) | CA2769977A1 (en) |
IN (1) | IN2012DN00904A (en) |
WO (1) | WO2011016468A1 (en) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1007351B (en) * | 1985-06-18 | 1990-03-28 | 沃纳兰伯特公司 | Be used as the preparation method of the aminoalkoxy benzopyrone of major tranquilizer and tranquillizer |
KR910006138B1 (en) | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | Cyclic amine derivatives |
US4921863A (en) | 1988-02-17 | 1990-05-01 | Eisai Co., Ltd. | Cyclic amine derivatives |
FR2672286B1 (en) | 1991-01-31 | 1994-11-18 | Synthelabo | DERIVATIVES OF 1- (4-CHLOROPHENYL) -2- [4- (PHENYLMETHYL) PIPERIDIN-1-YL] ETHANOL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
FR2696741B1 (en) | 1992-10-12 | 1994-11-25 | Synthelabo | 1- (4-Chlorophenyl) -2- [4 - [(4-fluorophenyl) methyl] piperidin-1-yl] ethanol derivatives, their preparation and their therapeutic use. |
FR2697251B1 (en) | 1992-10-22 | 1994-12-02 | Synthelabo | N-oxides of 1- (4-chlorophenyl) -2- [4 - [(4-fluorophenyl) methyl] piperidin-1-yl] ethanol derivatives, process for their preparation and their therapeutic application. |
ATE174915T1 (en) | 1994-10-31 | 1999-01-15 | Merck Patent Gmbh | BENZYLPIPERIDINE DERIVATIVES WITH HIGH AFFINITY FOR BINDING SITES OF AMINO ACID RECEPTORS |
CA2188485A1 (en) | 1995-11-17 | 1997-05-18 | Ronald J. Mattson | Piperidinylethylamide derivatives as serotonergic agents |
ZA9610745B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
WO1998007703A1 (en) | 1996-08-22 | 1998-02-26 | Meiji Seika Kaisha, Ltd. | Quinoline derivatives and psychotropic agent |
WO1998008816A1 (en) | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Oxindole derivatives and psychotropic drugs |
PE20000728A1 (en) | 1998-06-26 | 2000-08-21 | Cocensys Inc | HETEROCYCLES 4-BENZYL PIPERIDINE ALKYLSULFOXIDE AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS |
US6476051B2 (en) | 1999-12-17 | 2002-11-05 | Bristol-Myers Squibb Company | Antipsychotic heterocycle compounds |
ES2291329T3 (en) * | 2000-07-18 | 2008-03-01 | Dainippon Sumitomo Pharma Co., Ltd. | INHIBITORS OF SEROTONINE RECAPTATION. |
WO2003053928A1 (en) * | 2001-12-13 | 2003-07-03 | Sumitomo Pharmaceuticals Co., Ltd. | Serotonine reuptake inhibitor |
GB0227240D0 (en) | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
TWI391387B (en) | 2004-05-12 | 2013-04-01 | Eisai R&D Man Co Ltd | Indole derivative having piperidine ring |
TWI410420B (en) * | 2008-02-05 | 2013-10-01 | Dainippon Sumitomo Pharma Co | Benzylpiperidine compounds |
-
2010
- 2010-08-04 JP JP2011525903A patent/JPWO2011016468A1/en not_active Abandoned
- 2010-08-04 WO PCT/JP2010/063148 patent/WO2011016468A1/en active Application Filing
- 2010-08-04 IN IN904DEN2012 patent/IN2012DN00904A/en unknown
- 2010-08-04 CN CN2010800393087A patent/CN102482263A/en active Pending
- 2010-08-04 KR KR1020127004694A patent/KR20120051716A/en not_active Application Discontinuation
- 2010-08-04 US US13/388,623 patent/US8778970B2/en not_active Expired - Fee Related
- 2010-08-04 EP EP10806467A patent/EP2463286A4/en not_active Withdrawn
- 2010-08-04 CA CA2769977A patent/CA2769977A1/en not_active Abandoned
- 2010-08-04 AU AU2010279963A patent/AU2010279963A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2010279963A2 (en) | 2012-04-12 |
CN102482263A (en) | 2012-05-30 |
AU2010279963A1 (en) | 2012-02-23 |
EP2463286A1 (en) | 2012-06-13 |
KR20120051716A (en) | 2012-05-22 |
EP2463286A4 (en) | 2013-01-23 |
US8778970B2 (en) | 2014-07-15 |
WO2011016468A1 (en) | 2011-02-10 |
US20120130077A1 (en) | 2012-05-24 |
CA2769977A1 (en) | 2011-02-10 |
JPWO2011016468A1 (en) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200705099A (en) | Photosensitive resin composition and color filter using the same | |
MX346367B (en) | Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity. | |
CL2008002703A1 (en) | Compounds derived from 1,4-dihydro-2h-pyridazin-3-one; herbicidal composition comprising said compounds; weed control method; use of said compounds for weed control; and intermediate compounds. | |
AR108819A2 (en) | POLYMORPHIC FORMS OF A MACROCYCLIC HCV INHIBITOR | |
TW200744659A (en) | Preparation for preventing and ameliorating wrinkle | |
WO2009072581A1 (en) | Lactam compound or salt thereof, and ppar activator | |
ECSP10010060A (en) | SUBSTITUTED PIRAZOL DERIVATIVES | |
CR8827A (en) | FUSED HETEROCICLIC COMPOUND | |
CY1112705T1 (en) | SUSPENDED CIRCUIT COMPOUNDS | |
MX2011009354A (en) | Pyridazinone compound and use thereof. | |
MX2009010552A (en) | Peripheral opioid receptor antagonists and uses thereof. | |
ES2531324T3 (en) | Intermediate to produce a bicyclic gamma-amino acid derivative | |
MX336366B (en) | Peripheral opioid receptor and antagonists and uses thereof. | |
CR11245A (en) | IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME | |
CL2011002287A1 (en) | Compounds derived from 8-phenoxy-1,1-dioxide-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine, ampa and nmda receptor modulators; pharmaceutical composition; preparation procedure; and its use to treat progressive neurodegenerative diseases, Alzheimer's, Parkinson's, Huntington's chorea, among others; intermediate compound. | |
AR063805A1 (en) | TRIAZOL DERIVATIVES REPLACED AS KSP INHIBITORS. PHARMACEUTICAL COMPOSITIONS. | |
AR059837A1 (en) | ANTIPALUDIC COMPOUNDS WITH POLYAROMATIC STRUCTURE, A METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION | |
WO2009063990A1 (en) | Benzazepinone compound | |
WO2007144512A3 (en) | Diazeniumdiolate derivatives, method for the preparation thereof, pharmaceutical compositions thereof, and use of same in the fields of hypertension and cardiovascular pathologies | |
WO2008117871A1 (en) | Nitrogen-containing redox catalyst | |
WO2008078445A1 (en) | Polymerizable compounds and polymerizable compositions | |
WO2008149834A1 (en) | Pyrimidodiazepinone derivative | |
TW200833654A (en) | Polyhydric phenol compound and chemically amplified resist composition containing the same | |
AR064306A1 (en) | ANGIOTENSIN II RECEIVER ANTAGONISTS | |
TW200745153A (en) | Trehalose compound and pharmaceutical comprising the compound |